(Total Views: 257)
Posted On: 06/29/2017 2:27:24 PM
Post# of 72446
It won't be 100% so the timer has started for the interim result. I like it because the shorts won't know when to cover in Q3.
"Our planned interim analysis, which targets the majority of patients who have completed at least six weeks of treatment in the Phase 2b trial will give us our first hard look at just how we're doing. We anticipate interim analysis for Prurisol in the Phase 2b moderate to severe psoriatic population to occur as I mentioned earlier in 3Q 2017."
https://seekingalpha.com/article/4080068-inno...art=single
"Our planned interim analysis, which targets the majority of patients who have completed at least six weeks of treatment in the Phase 2b trial will give us our first hard look at just how we're doing. We anticipate interim analysis for Prurisol in the Phase 2b moderate to severe psoriatic population to occur as I mentioned earlier in 3Q 2017."
https://seekingalpha.com/article/4080068-inno...art=single
Quote:
My hope is the interim look will not be based off 100% enrollment and will come sooner.
(2)
(0)
